期刊文献+

以右美沙芬为探针测定大鼠肝微粒体中CYP2D6酶活性及动力学分析 被引量:2

Determination of CYP2D6 activity in rat liver microsomes and study on its kinetics with dextromethorphan probe in vitro
原文传递
导出
摘要 目的建立大鼠肝微粒体中细胞色素P450(CYP)2D6酶活性的检测方法,以右美沙芬为探针底物进行体外酶动力学分析,为相关药物代谢研究提供参考依据。方法采用高效液相色谱-荧光检测(HPLC-FLD)方法提高检测灵敏度。通过优化大鼠肝微粒体孵育体系的反应条件,建立稳定的动力学评价方法。以Graphpad prism 5.01软件绘制米曼动力学曲线并计算V_(max)与K_m值。结果右美沙芬与其代谢产物右啡烷分离良好且无其他内源性物质干扰。右啡烷检测限为5 nmol·L^(-1)(S/N>3),定量下限为0.015μmol·L^(-1),线性范围为0.015~7.5μmol·L^(-1)。测定方法重现性好且稳定。经优化条件后测定,不同浓度的右美沙芬在0.2 mg·mL^(-1)蛋白浓度下,孵育10 min,测得动力学参数V_(max)为(1.075±0.060)nmol·min^(-1)·mg^(-1)pro,K_m为(7.470±0.983)μmol·L^(-1)。结论高效液相色谱结合荧光检测法可以有效提高灵敏度,此大鼠微粒体孵育体系的建立可应用于体外CYP2D6酶活性的测定及酶动力学研究。 AIM To establish a method for measuring CYP2D6 activity in rat liver microsomes, and investigate the enzyme kenetics of CYP2D6 using dextromethorphan as a probe- substrate in order to better understand of the relevant drug metabolism. METHODS Analytes were examined by high- performance liquid chromatography with fluorescence detector (HPLC- FLD) in order to improve the detection sensitivity. By optimizing the reaction conditions of incubation system for rat liver microsomes, a method for evaluating CYP2D6 activity and enzyme kinetics was established. The kinetic parameters, V/max and Km were calculated byGraphpad prism 5.01. RESULTS Dextromethorphan and its metabolites (dextrorphan) were separated well without endogenous substances interference. The detectable limit of dextrorphan was 5 μmol· L-1 (S/N 〉 3) and the quantitative lower limit was 0.015 μmol· L-1. The linear range of calibration curve was from 0.015 μmol·L-1 to 7.5 μmol·L-1. The reproducibility and stability of this method were reliable. The kinetic parameters, V/max and Km were ( 1.075 ± 0.060) nmol·min-1 mg-l pro and (7.470 ± 0.983) μmol·L-i, respectively. CONCLUSION The high-performance liquid chromatography with fluorescence detection can effectively improve the sensitivity. Moreover, the rat microsomal incubation system can be applied for CYP2D6 activity measurement and enzyme kinetics studies in vitro.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2013年第9期744-748,共5页 Chinese Journal of New Drugs and Clinical Remedies
基金 国家科技重大专项(2010ZX09401-306-1-1) 重庆科技创新能力建设项目(2010AA5058)
关键词 色谱法 高压液相 右美沙芬 大鼠 微粒体 右啡烷 细胞色素P450 CYP2D6 chromatography, high pressure liquid dextromethorphan rats microsomes, liver dextrorphan cytochrome P-450 CYP2D6
  • 相关文献

参考文献13

  • 1胡道德,顾磊,姚慧娟,刘文,王松坡,刘皋林.Cocktail探针药物评价淫羊藿提取物对大鼠CYP450酶的影响[J].中国新药与临床杂志,2009,28(5):337-341. 被引量:10
  • 2SUBRAMANIAN M, LOW M, LOCUSON CW, et hi. CYP2D6- CYP2C9 protein- protein interactions and isoform- selective effects on substrate binding and catalysis[J]. Drug Metab Dispos, 2009, 37(8) : 1682-1689.
  • 3LEE HW, KIM DW, PHAPALE PB, et cd. In vitro inhibito effects of Wen-pi-tang-Hab-Wu-ling-san on human eytochrome P450 isoforms[J]. J Clin Pharm Ther, 2011, 36(4): 496-503.
  • 4SHEN HW, HE MM, LIU HF, et cd. Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17 [J]. Drug Metab Dispos, 2007, 35 (8) : 1292- 1300.
  • 5GUENGERICH FP. Cytochrome P450s and other enzymes in drug metabolism and toxicity[J]. APPS J, 2006, 8( 1 ) : EI01-E1 I 1.
  • 6GNOJKOWSKI J, BAER-DUBOWSKA W, KLIMEK D, eta!. Effect of toluidines on drug metabolizing enzymes in rat liver, kidney and lung[J]. Toxicology, 1984, 32(4) : 335-342.
  • 7郭延垒,于超,杨竹,王应雄,张艳辉,张有金.HPLC法测定大鼠UGT1A6的酶活性及体外动力学分析[J].药物分析杂志,2012,32(4):717-720. 被引量:3
  • 8温彬宇,李豪,王岚,王嗣岑.Beagle犬肝微粒体中葛根素的HPLC-ESI-MS测定及代谢动力学研究[J].中国中药杂志,2008,33(23):2834-2837. 被引量:4
  • 9ZHAO Y, HELLUM BH, LIANG A, et cd. The in vitro inhibition of human CYP1A2, CYP2D6 and CYP3A4 by tetrahydropalmatine, neferine and berberine [J]. Phytother Res, 2012, 26(2): 277-283.
  • 10ZHENG J, CHEN B, JIANG B, et ol. The effects of puerarin on CYP2D6 and CYP1A2 activities in vivo[J]. Arch Pharm Res, 2010, 33(2) : 243-246.

二级参考文献34

  • 1金科涛,王宇光,徐彭,高月.HPLC测定大鼠肝微粒体P450活性方法学研究进展[J].药物分析杂志,2006,26(3):415-419. 被引量:25
  • 2崔升淼,赵春顺,高坤,毛晶晶,何仲贵.大鼠肝微粒体中葛根素的液相色谱-质谱测定法及药物代谢动力学[J].沈阳药科大学学报,2007,24(1):32-36. 被引量:27
  • 3朱丽华.现代中药BG-Ⅱ-02制备工艺及质量标准的研究[D].西安:西安交通大学,2005.
  • 4Jeong Sook Lee, John Mamo, Nerissa Ho, et al. The effect of Puerariae radix on lipoprotein metabolism in liver and intestinal cells [J]. BMC Complement Altern Med, 2002, 2 (1): 12.
  • 5M C Guerra, E Speroni, M Broccoli, et al. Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP-catalysed drug metabolism [J]. Life Sci, 2000, 67 (7) : 2997.
  • 6Lowry O H, Rosebrou G, Farr A L, et al. Protein measurement with the Folin phenol reagent [J]. J Biol Chem, 1951, 193 (1) : 265.
  • 7Bjomsson T D, Callaghan J T, Einolf H J, et al. The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufactures of America (PhRMA) perspective [J]. Drug Metab Dispos, 2003, 31 (7) : 518.
  • 8D A Smith, Hvande Waterbeemd, D K Walker, et al. Pharmacokinetics and metabolism in drug design [ M ]. Newyork : John Wiley & Sons, 2001 : 137.
  • 9LAHOZ A, DONATO MT, PICAZO L, et al. Determination of major human cytochrome P450s activities in 96-well plates using liquid chromatography tandem mass spectrometry [J]. Toxicol In Vitro, 2007, 21(7): 1247-1252.
  • 10LAINE JE, AURIOLA S, PASANEN M, et al. Acetaminophen bioaetivation by human eytoehrome P450 enzymes and animal microsomes[J]. Xenobiotica, 2009, 39(1) : 11-21.

共引文献595

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部